comparemela.com

Latest Breaking News On - Global initiative on obstructive lung disease - Page 1 : comparemela.com

New data presented at ATS 2024 show the potential of TEZSPIRE to play a role in the future treatment of chronic obstructive pulmonary disease

WILMINGTON, Del. (BUSINESS WIRE) May 19, 2024

United kingdomUnited statesLymphopoietin isoformsDave singhBrendan mcevoyJillian gonzalesSharon barrGlobal initiative on obstructive lung diseaseCenters for diseaseInternational conferenceAmerican thoracic societyNational heartAmerican lung associationUniversity of manchesterBlood instituteGlobal initiative for chronic obstructive lung disease

AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024 showcasing strength of its broad pipeline and portfolio

New data for TEZSPIRE and BREZTRI demonstrate AstraZeneca’s innovation and commitment to transform care in COPD .

San diegoUnited statesEast sussexUnited kingdomSharon barrLymphopoietin isoformsAmerican lung associationInternational conferenceGlobal initiative on obstructive lung diseaseKyowa kirin co ltdAmerican thoracic society international conferenceGlobal asthma networkBiowa incAmerican partnership for eosinophilic disordersNational heartBlood institute

AstraZeneca announces initiation of THARROS – a Phase III clinical trial investigating the potential of BREZTRI to improve cardiopulmonary outcomes in people with COPD

THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a key driver of mortality, in COPD First patients dosed in.

United statesNew yorkUnited kingdomFernando martinezSharon barrFormoterol fumarateEuropean respiratory society congressNational heartDivision of pulmonaryGlobal initiative on obstructive lung diseaseBlood instituteCenters for diseaseGlobal initiative for chronic obstructive lung diseaseInternational investigatorData networkHarvard medical school

vimarsana © 2020. All Rights Reserved.